NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure–Activity Insights
Journal of Medicinal Chemistry · 28.08.2025 · 68 (16) · 17485-17498
DOI: 10.1021/acs.jmedchem.5c01008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 15.08.2025. Verfasst von Viktoriia Baksheeva und 9 weiteren Autor:innen. Beteiligte Einrichtung: CNRS, INP, Inst Neurophysiopathol, Aix-Marseille Univ, 13005 Marseille, France. Hauptthemen laut MEDLINE: Antineoplastic Agents, Tubulin, Tubulin Modulators. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancerop?le PACA.
Abstract (Originalsprache)
Microtubule targeting agents (MTAs) constitute a vital category of tubulin-binding compounds deployed across anticancer therapies. Despite the array of MTA drugs developed by pharmaceutical entities, the quest for novel efficacious molecules continues unabated. We unveil an innovative in vitro MTA screening methodology employing nano-differential scanning fluorimetry (nanoDSF), presenting distinct advantages over known assays. This novel approach not only assesses compound-tubulin binding but also quantitatively analyzes its impact on tubulin polymerization, facilitating structure–activity relationship discovery. The proposed nanoDSF assay was rigorously validated using the Prestwick Chemical Library, which encompasses 1520 approved compounds, successfully identifying all previously known MTAs. This screening has unearthed potential antitubulin agents among drugs currently utilized for unrelated medical conditions, offering insights into their mechanisms of action in inhibiting cancer cell proliferation and/or inducing cytotoxicity. Finally, we have identified a previously unrecognized structure–activity relationship within the carbendazim and phenothiazine drug clusters, providing valuable insights for the rational optimization of compounds from these families. These discoveries open new opportunities for drug repositioning of the newly identified MTAs and significantly streamline the screening process of large chemical libraries for MTAs with novel chemical scaffolds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CNRS, INP, Inst Neurophysiopathol, Aix-Marseille Univ, 13005 Marseille, France.
- CNRS, INSERM, Institut Paoli Calmettes, CRCM, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille Univ, 13009 Marseille, France.
- PINT, Plateforme Interactions moléculaires Timone, Faculté des Sciences Médicales et Paramédicales, Aix-Marseille Univ, 13005 Marseille, France.
- Faculty of Bioengineering and Bioinformatics, Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia.
- Department of Computational Biology, Sirius University of Science and Technology, 354340 Sirius, Russia.
ORCID-Profile: Viktoriia Baksheeva, Philippe Roche, Xavier Morelli, Philipp O Tsvetkov
Förderung
- Cancerop?le PACA
Zitieren
APA
Baksheeva, V., La Rocca, R., Allegro, D., Derviaux, C., Pasquier, E., Roche, P., Morelli, X., Devred, F., Golovin, A. V., & Tsvetkov, P. O. (2025). NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure–Activity Insights. Journal of Medicinal Chemistry, 68(16), 17485-17498. https://doi.org/10.1021/acs.jmedchem.5c01008
Vancouver
Baksheeva V, La Rocca R, Allegro D, Derviaux C, Pasquier E, Roche P, et al. NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure–Activity Insights. Journal of Medicinal Chemistry. 2025;68(16):17485-17498. doi:10.1021/acs.jmedchem.5c01008
BibTeX
@article{Baksheeva2025,
author = {Baksheeva, Viktoriia and La Rocca, Romain and Allegro, Diane and Derviaux, Carine and Pasquier, Eddy and Roche, Philippe and Morelli, Xavier and Devred, François and Golovin, Andrey V and Tsvetkov, Philipp O},
title = {NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure–Activity Insights},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {16},
pages = {17485--17498},
doi = {10.1021/acs.jmedchem.5c01008}
}
EUVIMED